Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDMEDICA A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   3.5% 3.4% 15.0% 14.4% 13.6% 3.8% 8.2% 8.0%   Credit score (0-100)   55 55 13 14 16 50 30 31   Credit rating   BBB BBB BB BB BB BBB BB BB   Credit limit (kEUR)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kEUR)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,167 1,254 888 1,002 635 588 0.0 0.0   EBITDA   2,167 1,254 888 1,002 635 588 0.0 0.0   EBIT   1,953 1,044 691 1,002 635 588 0.0 0.0   Pre-tax profit (PTP)   1,838.4 1,050.7 792.7 1,029.1 965.4 1,047.3 0.0 0.0   Net earnings   1,393.3 782.0 608.6 784.6 723.2 765.9 0.0 0.0   Pre-tax profit without non-rec. items   1,838 1,051 793 1,029 965 1,047 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kEUR)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   9,683 10,467 11,074 11,845 12,549 13,283 13,275 13,275   Interest-bearing liabilities   0.0 288 291 294 305 320 0.0 0.0   Balance sheet total (assets)   9,989 10,849 11,383 12,202 13,103 13,871 13,275 13,275   Net Debt   -90.4 240 238 254 274 309 -13,275 -13,275     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,167 1,254 888 1,002 635 588 0.0 0.0   Gross profit growth   -26.5% -42.1% -29.2% 12.8% -36.6% -7.4% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9,989 10,849 11,383 12,202 13,103 13,871 13,275 13,275   Balance sheet change%   11.4% 8.6% 4.9% 7.2% 7.4% 5.9% -4.3% 0.0%   Added value   2,167.0 1,254.4 887.8 1,001.7 634.8 587.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -586 -422 -393 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   90.1% 83.2% 77.9% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   19.4% 10.1% 7.2% 8.8% 7.8% 8.0% 0.0% 0.0%   ROI %   20.4% 10.3% 7.2% 8.8% 7.9% 8.1% 0.0% 0.0%   ROE %   15.5% 7.8% 5.7% 6.8% 5.9% 5.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   96.9% 96.5% 97.3% 97.1% 95.8% 95.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -4.2% 19.1% 26.8% 25.3% 43.1% 52.6% 0.0% 0.0%   Gearing %   0.0% 2.8% 2.6% 2.5% 2.4% 2.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   41.1% 1.9% 1.7% 1.7% 6.5% 8.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   34.5 29.9 36.9 36.6 25.2 23.5 0.0 0.0   Current Ratio   35.5 29.9 36.9 36.6 25.2 23.5 0.0 0.0   Cash and cash equivalent   90.4 48.2 53.4 40.1 30.9 11.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   9,312.3 10,296.0 11,074.4 11,868.3 12,582.7 13,207.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0